Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose
Fabio Fiorino, Anna Sicuranza, Annalisa Ciabattini, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1480-1480
Open Access | Times Cited: 24

Showing 24 citing articles:

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Fabio Fiorino, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 97
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration
Giuditta Guerrini, Sabrina Gioria, Aisha V. Sauer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8838-8838
Open Access | Times Cited: 52
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
Jacopo Polvere, Massimiliano Fabbiani, G Pastore, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
G Pastore, Jacopo Polvere, Fabio Fiorino, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 432-444
Open Access | Times Cited: 5
Efficacy of COVID-19 Vaccines in Patients with Hematological Malignancy Compared to Healthy Controls: A Systematic Review and Meta-analysis
Anindita Das Barshan, Emilie Louise Akiko Matsumoto-Takahashi
JMA Journal (2024) Vol. 7, Iss. 2, pp. 153-171
Open Access | Times Cited: 4
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients
Fabio Fiorino, Annalisa Ciabattini, Anna Sicuranza, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Leishmania Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised Patients
Andrea Duminuco, Salvatore Scarso, Alessandra Cupri, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 578-578
Open Access | Times Cited: 11
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1706-1706
Open Access | Times Cited: 10
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
Elena Pettini, Annalisa Ciabattini, G Pastore, et al.
Blood Advances (2022) Vol. 6, Iss. 7, pp. 2247-2249
Open Access | Times Cited: 15
Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies
Lucy Cook, Gillian O’Dell, Eleni Vourvou, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 15
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109046-109046
Open Access | Times Cited: 14
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2
Elena Pettini, Donata Medaglini, Annalisa Ciabattini
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
(2023)
Open Access | Times Cited: 6
Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2
Bruno Fattizzo, Nicolò Rampi, Wilma Barcellini
Blood Reviews (2023) Vol. 60, pp. 101077-101077
Open Access | Times Cited: 4
Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib
Daisuke Ikeda, Toshiki Terao, Daisuke Miura, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity
Giuseppe Auteri, Daniela Bartoletti, Christian Di Pietro, et al.
Leukemia Research (2022) Vol. 116, pp. 106819-106819
Open Access | Times Cited: 6
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
F Panza, Fabio Fiorino, G Pastore, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2607-2607
Open Access | Times Cited: 3
Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine
Massimo Breccia, Alfonso Piciocchi, Monica Messina, et al.
Leukemia (2022) Vol. 36, Iss. 10, pp. 2548-2550
Open Access | Times Cited: 5
Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
(2024)
Closed Access
Blood Disorders: Response and Achille Heel in the Framework of SARS-Cov-2- a Short Review
Maria Giovanna Buonomenna
Elsevier eBooks (2024), pp. 455-466
Closed Access
The Humoral Response to SARS-CoV-2 Vaccine in Hemodialysis Patients Is Correlated with Nutritional Status
Merav Jacobson-Naftali, Odile Azoulay, Sigal Frishman, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1141-1141
Open Access | Times Cited: 1
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy
Jacopo Polvere, Massimiliano Fabbiani, G Pastore, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Breakthrough infections in MPN-COVID vaccinated patients
Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 11
Open Access
Page 1

Scroll to top